Aperio Group’s Turning Point Therapeutics TPTX Stock Holding History
Bought
Maintained
Sold
Other funds holding TPTX
Aperio Group's TPTX Position: Q4 2020 in Review
Aperio Group opened a new position in Turning Point Therapeutics (TPTX) in Q4 2020: 2,666 shares worth $325K. The stake represents ﹤0.01% of the portfolio and ranks #2155 among its holdings.
193 funds tracked by Wall St. Rank hold TPTX as of Q4 2020.
- Aperio Group held 2,666 shares of Turning Point Therapeutics worth $325K as of Q4 2020.
- Turning Point Therapeutics was a new Aperio Group position in Q4 2020.
- Turning Point Therapeutics made up ﹤0.01% of Aperio Group's portfolio in Q4 2020, its #2155 holding.
- 193 funds tracked by Wall St. Rank held Turning Point Therapeutics as of Q4 2020.
Based on Aperio Group's 13F filing for Q4 2020, filed 5 Feb 2021.